Yes. The CapillusPro device (Capillus laser therapy cap model with 272 laser diodes) has been clinically proven in a double-blind, independently-reviewed clinical trial with results published in a peer-reviewed medical journal. The double-blind clinical study for the CapillusPro was registered on ClinicalTrials.gov and was managed by a neutral third party.* The clinical trial data indicated that low-level laser treatment of the scalp for 17 weeks with the CapillusPro device, significantly improved hair counts by 51% in those study participants who used the active (non-placebo) device. Subjects were able to use the device on a self-treatment home-use basis and no adverse events or side-effects were reported. The CapillusPro was proven to be a safe and effective treatment for androgenic alopecia within the appropriate stages of hair loss and skin tones as per FDA clearance.
*See details of clinical trials at ClinicalTrials.gov
There have also been many other clinical trials that support the efficacy of low-level laser technology for treatment of androgenetic alopecia.